TG Therapeutics Inc (NASDAQ:TGTX) traded at $38.85 at last check on current trade day and made an upward move of 1.07% on its previous day’s price. Analysts tracking the company’s growth have also given it a consensus growth in revenue estimated at 117.32M, with a
TG Therapeutics Inc (NASDAQ:TGTX) shares, rose in value, with the stock price down by -1.43% to the previous day’s close as strong demand from buyers drove the stock to $35.11. Actively observing the price movement in the last trading, the stock closed the session at
The trading price of TG Therapeutics Inc (NASDAQ:TGTX) floating higher at last check on current market day and closing at $34.81, 15.70% higher than its previous close. In examining the 52-week price action we see that the stock hit a 52-week high of $36.84 and
The trading price of TG Therapeutics Inc (NASDAQ:TGTX) closed lower on Tuesday, February 11, and closed at $31.11, -3.53% lower than its previous close. Traders who pay close attention to intraday price movement should know that it fluctuated between $30.88 and $32.0457. In examining the
TG Therapeutics Inc (NASDAQ:TGTX) price on Thursday, February 06, rose 0.99% above its previous day’s close as an upside momentum from buyers pushed the stock’s value to $33.50. A look at the stock’s price movement, the close in the last trading session was $33.17, moving
TG Therapeutics Inc (NASDAQ:TGTX) price closed lower on Friday, January 31, and dropping -4.98% below its previous close. A look at the daily price movement shows that the last close reads $33.36, with intraday deals fluctuated between $31.62 and $33.74. The company’s 5Y monthly beta
Stocks Register is a comprehensive online news hub delivering daily updates on various facets of U.S. life, including business, technology, politics, economy, culture, sports, and noteworthy global events.
